Skip to main content
. 2018 Jun 19;10:55. doi: 10.1186/s13195-018-0378-7

Fig. 5.

Fig. 5

The effect of tau294–305 epitope to hepatitis B core immunodominant region (T294-HBc) virus-like particle (VLP) immunization on the levels of insoluble tau in Tau.P301S. The radioimmunoprecipitation assay buffer (RIPA)-insoluble tau in mouse brain homogenates was subjected to SDS-PAGE and then transferred onto nitrocellulose membrane. The tau protein was probed by human tau-specific antibody HT7 (1:3000) (a) and total tau antibody tau 5 (1:2000) (b), respectively. The Western blot signals were quantified using IPwin5 Image-Pro Plus software, and β-actin was used as a control (compared with adjuvant-treated Tau.P301S mice; *P < 0.05, Student’s t test)